Dr. Jay Bakul Shah, MD

Dr. Shah practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Shah's NPI, 1487897948, was assigned on April 14, 2009. Dr. Shah graduated from Vagelos College of Physicians and Surgeons in 2002. Dr. Shah holds California license C145834.

Dr. Shah's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Shah's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Shah to 1 more hospital, named with a free account. Dr. Shah's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Shah is board certified in urology by the American Board of Urology. Dmand AI has Dr. Shah's licenses on file in 3 states: California, Oregon and Texas.

Dmand AI lists enlarged prostate transurethral surgery (TURP), prostate cancer and urinary endoscopy among the conditions Dr. Shah treats.

CMS data shows 154 Medicare services from Dr. Shah across 3 procedure codes in 2024, for 107 Medicare patients. Medicare paid $14,294 for them.

CMS counts 107 Medicare patients who saw Dr. Shah in 2024. The largest group is 75 to 84, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 68, with 25% women.

In 2024, Dr. Shah wrote 40 Medicare Part D claims for 29 patients. 80% of them were for generic drugs. CMS names the drug for 27 of them, across 1 drug with 11 or more claims each, at $140 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shah for performance year 2024, reported as part of a group. Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shah as offering telehealth.

Dmand AI links 49 papers to Dr. Shah, published from 2007 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Prostatic Neoplasms. Dr. Shah has published most often in BJU Int. Dr. Shah's most frequent co-authors are Jay Shah, MD, Colin P. Dinney, MD and Ashish M. Kamat, MD.

Dmand AI links Dr. Shah to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Urinary Bladder Neoplasms and Urinary Bladder Diseases.

CMS Open Payments shows 36 general payments to Dr. Shah from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Photocure Inc paid the most, $1,484.

Dr. Shah graduated from Vagelos College of Physicians and Surgeons in 2002.

Dr. Shah is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.